Alterations of the tumor suppressor gene p53 are uncommon in dierentiated thyroid neoplasia but are detected at high frequency in anaplastic thyroid carcinoma suggesting that impaired p53 function may contribute to the undierentiated and highly aggressive phenotype of these tumors. Eects of wild type p53 (wtp53) re-expression were investigated in a human anaplastic thyroid carcinoma cell line (ARO) expressing a mutated p53. ARO cells were stably transfected with the temperature-sensitive p53 Val 135 gene (ts-p53) which exhibits wild type-like activity at 328C. Exogenous wtp53 function in ARO-tsp53 clones was assessed by evaluating its transcriptional activity on a CAT reporter vector containing p53 binding sites. At 328C, a signi®cant reduction in the proliferation rate (%50%) was observed, with accumulation of cells in the G 0 /G 1 phase of the cell cycle. This eect was accompanied by induction of the expression of the growth inhibitor p21/ Waf1 gene. At 328C, ARO-tsp53 clones also showed a marked impairment of their tumorigenic potential. Furthermore, transfected clones re-acquired the ability to respond to thyrotropin (TSH) stimulation showing an increased expression of thyroid-speci®c genes (thyroglobulin, thyroperoxidase and TSH receptor). In conclusion, re-expression of wt-p53 activity in ARO cells, inhibits cell proliferation and restores responsiveness to physiological stimuli.
Introduction
Thyroid tumorigenesis is characterized by progressive impairment of cell dierentiation, resulting in loss of the highly specialized functions of the thyrocyte and acquisition of a more malignant behaviour. Thyroid neoplasia, in fact, exhibit a wide variety of biological and clinical phenotypes which range from benign lesions such as micro/macro-follicular nodules and follicular adenomas, to malignant tumors such as dierentiated follicular and papillary carcinomas and highly aggressive anaplastic carcinomas (Ingbar, 1985; Fagin, 1994) . At the molecular level, these clinical and biological phenotypes are associated with accumulation of speci®c genetic alterations, which lead to activation of oncogenes and/or inactivation of tumor suppressor genes, thought to play a key role in the development of thyroid neoplasia (Fagin, 1994) . The proposed sequence of molecular events characterizing thyroid tumorigenesis, considers the alteration of the tumor suppressor gene p53 as a late event, since it has been found almost exclusively associated with poorly dierentiated and anaplastic carcinomas (Wright et al., 1991; Ito et al., 1992; Fagin et al., 1993; Donghi et al., 1993) . These tumor histotypes exhibit strong malignant behaviour, characterized by high invasiveness, complete loss of thyroid-speci®c biochemical markers, such as thyroglobulin (Tg), thyroperoxidase (TPO) and thyrotropin receptor (TSH-R), and impairment of thyroid dierentiated functions such as iodine uptake, hormone secretion and response to thyrotropin (TSH) stimulation (Ingbar, 1985) .
The frequent coexistence of p53 mutations with the most advanced and undierentiated stages of tumors arising from various tissues (Prokocimer and Rotter, 1994; Grenblatt et al., 1994) and the inability of mutant p53 alone to induce malignant transformation of cell cultures (Hinds et al., 1989; Eliyahu et al., 1989; Battista et al., 1995) suggest that, at least for certain tumor histotypes, p53 alterations mostly contribute to the transition towards more malignant states rather than to the initiation of transformation. This hypothesis is also supported by p53-null mice, which develop normally but, in comparison to syngenic control animals, exhibit an altered tumor spectrum, characterized by the more frequent emergence, at an earlier age, of poorly dierentiated carciomas (Donehower et al., 1992) .
It has also been suggested that p53 plays a role in the process of cell dierentiation and that p53 alterations may therefore interfere with cell commitment toward dierentiation (Shaulsky et al., 1991b; Aloni-Grinstein et al., 1993; Battista et al., 1995; Fagin et al., 1996; Soddu et al., 1996) . However, direct involvement of p53 along the pathway that leads to biochemical expression of cell-speci®c dierentiation markers, is not completely de®ned, having been demonstrated only in selected cell types, such as those pertaining to the erythroleukemic lineage (Shaulsky et al., 1991a; Feinstein et al., 1992; Aloni-Grinstein et al., 1993; Johnson et al., 1993) .
In the present study, we have investigated whether wild type p53 (wt-p53) is able to suppress the aggressive and undierentiated phenotype of thyroid anaplastic carcinoma. A temperature-sensitive p53 (ts-p53) has been stably transfected into a human undierentiated thyroid carcinoma cell line (ARO) expressing a mutated p53. The tumor suppressor activity of wt-p53 has been evaluated at the permissive temperature (328C) in terms of cell proliferation, in vitro tumorigenic potential and thyroid-speci®c dierentiation. The results show that recovery of wt-p53 activity reduces proliferation and tumorigenicity of ARO cells and restores their responsiveness to physiological dierentiation stimuli.
Results

Establishment of ARO cell clones expressing exogenous wt-p53
Eects of wt-p53 re-expression were evaluated in the undierentiated human thyroid carcinoma ARO cell line which is characterized by the deletion of one p53 allele and the mutation of the other allele at codon 273 (His 273 ). ARO cells were stably transfected with the ts-p53 or Neo plasmids and, after G418 selection, several clones were obtained. Parental cells and transfected clones were grown for 3 days at the permissive temperature (328C) and then assayed for the presence and localization of p53 protein by indirect immuno¯uorescence using monoclonal antibody PAb421. At 378C the p53¯uorescence signal was mostly localized in the cytoplasm (data not shown). At 328C, ARO-tsp53 clones showed a marked¯uorescence, predominantly localized at nuclear level, while ARO parental cells and ARONeo showed only a faint¯uorescence. The nuclear localization at 328C of ts-p53 in ARO transfected clones suggests the acquisition of wild type conformation (Ginsberg et al., 1991) . On the basis of the immuno¯uorescence staining, four ARO-tsp53 positive clones, with varying degrees of¯uorescence intensity (ARO-4F5ARO-8%ARO-55ARO-1F), and the control ARO-Neo, were selected ( Figure 1 ). Each clone showed about 80% positive cells with heterogeneity in the nuclear staining, typical of p53¯uorescence (Ginsberg et al., 1991; Lu et al., 1992) . The expression of p53 protein was further assessed by Western blot analysis (data not shown). Using the anti-p53 PAb240 antibody, which recognizes mutant mammalian p53 protein, two dierent bands, corresponding to the human endogenous and murine exogenous proteins, were observed, thus con®rming the presence of the transfected ts-p53 in the selected clones. On the contrary, ARO parental and ARO-Neo cells generated a unique band corresponding to the endogenous p53.
Transcriptional activity of exogenous wt-p53
Several p53 mutant proteins, including the His 273 present in ARO cells, act in a dominant-negative manner by forming mutant/wild type heterotetramers, thus interfering with the activity of wild type p53 (Milner and Medcalf, 1991; Kern et al., 1992; Donehower and Bradley, 1993) . We therefore tested whether exogenous ts-p53, exhibiting wild type-like activity, might overcome the dominant negative action of the endogenous mutant protein.
The function of exogenous p53 was evaluated by measuring its transcriptional activity on a CAT reporter vector encompassing p53 binding sites (PG 13 -CAT). ARO-tsp53 (ARO-4F and ARO-1F) and ARO-Neo (control) cells were transiently transfected with PG 13 -CAT construct or a CAT construct containing a mutated sequence, unable to interact with wt-p53 (MG 15 -CAT). Figure 2 shows a signi®cant induction of CAT activity in ARO-tsp53 clones transfected with the PG 13 CAT construct and maintained at 328C, but not in ARONeo control cells. Interestingly, the induction of CAT activity directly correlated with the intensity of the p53 immuno¯uorescence staining exhibited by ARO-tsp53 clones (ARO-4F5ARO-1F). The speci®city of wt-p53 transcriptional activity was evidenced by the lack of CAT induction when the MG 15 -CAT construct was used ( Figure 2 ). As expected, when ARO-tsp53 and ARONeo cells were incubated at 378C, CAT activity was absent, independently of the transfected constructs (data not shown). These ®ndings demonstrate that, at the permissive temperature, ts-p53 expression generated adequate wild type-like activity in a cell context where a mutated dominant negative p53 is co-expressed. 
Wt-p53 inhibits ARO cell proliferation
To study the tumor suppressor activity of exogenous p53, cell proliferation of ARO-tsp53 clones was evaluated. The proliferation rate of ARO-tsp53 clones was determined by counting the number of viable and dead cells. At 378C, all clones shared the same proliferation pattern (Figure 3a) indicating that, at this temperature, ts-p53 expression does not aect ARO cell growth. On the contrary, at 328C, the proliferation of the various ARO-tsp53 clones was signi®cantly inhibited (Figure 3b ).
Inhibition of cell proliferation by wt-p53 may be the consequence of either an increase of cell death and/or accumulation in the G 0 /G 1 phase of the cell cycle. However, when the viability rate was considered, no signi®cant dierence was observed between control ARO-Neo and ARO-tsp53 clones (Figure 3c ), indicating that the reduction in the proliferation rate of AROtsp53 clones could not be attributed to an increase in p53-induced cell death.
The eect of ts-p53 on ARO cell proliferation was therefore evaluated by¯ow cytometric analysis of cellular DNA content. Cell cycle analysis, performed at day 9 on cells cultured at 328C, indicated that the percentage of cells in the G 0 /G 1 phase was higher in ARO-tsp53 clones (ARO-4F and ARO-8) compared to controls ( Figure 4 ). The corresponding DNA histograms did not show subdiploid peaks suggestive of apoptotic death, in good agreement with the cell viability pro®le reported in Figure 3c . To ascertain whether a progressive and time-dependent impairment of G 1 /S transition occurred, cell cycle analysis of AROtsp53 and control ARO-Neo and ARO parental cells, was performed at dierent day intervals. Analysis of cell proliferation index revealed a reduction of the progression of ARO-tsp53 cells into the growth fraction (S+G 2 /M) as compared to controls, indicating that, exogenous ts-p53 expression, rather than causing a progressive accumulation of cells in G 1 generates a delay of G 1 /S transition, with an overall prolongation of the cell cycle (Table 1 ). These data demonstrate that wt-p53 re-expression reduces ARO cell proliferation rate and causes a 
p21/Waf1 induction in ARO cells
The p21/Waf1 inhibitor of cyclin-dependent kinases is believed to be the main downstream eector of p53 action in the G 1 phase of the cell cycle (Hunter, 1993; El-Deiry et al., 1994; Slebos et al., 1994) . We therefore veri®ed whether the inhibition of cell proliferation observed in ARO-tsp53 clones was associated with transcriptional regulation of the p21/Waf1 gene by analysing its mRNA levels in ARO-tsp53 and ARONeo clones cultured at 378C or 328C for a total period of 7 days. As expected, at 378C, p21 mRNA levels were not induced, showing a barely detectable signal ( Figure  5 ). On the contrary, a strong increase (14 ± 88 relative fold induction over values at 378C) of p21/Waf1 mRNA levels was observed in ARO-tsp53 cells cultured at 328C ( Figure 5 and Table 2 , w/o TSH). Almost undetectable p21/Waf1 mRNA expression was also observed in ARO-Neo cells, independently of culture conditions. These results indicate that, in ARO-tsp53 cells, the eect of wt-p53 re-expression on cell proliferation is, at least in part, mediated by transcriptional induction of the p21/Waf1 gene.
Wt-p53 reduces in vitro tumorigenic potential of ARO cells
A relatively good parameter to evaluate the eectiveness of a tumor suppressor agent is the ability to inhibit colony formation in a semisolid medium. A soft-agar assay was therefore performed to evaluate whether exogenous wild type p53 action might reduce the in vitro tumorigenic potential of ARO-tsp53 clones. After 2 weeks incubation at 328C (Figure 6a ), the ability of ARO-tsp53 clones to form colonies (450 cells/colony) was strongly reduced (ARO-1F, ARO-5 and ARO-8 cells: 0 colonies/plate; ARO-4F cells: 43 colonies/plate) in comparison to controls (parental ARO and ARONeo cells: 480 colonies/plate). On the contrary, at 378C (Figure 6b ), all clones exhibited a strong anchorageindependent growth (4200 colonies/plate for each clone). The lower number of colonies obtained after parental ARO and ARO-Neo cells incubation at 328C, as compared to 378C, was dependent upon the lower incubation temperature used, total colony number approaching that observed at 378C after extension of cell incubation at 328C for an additional week.
These data clearly indicate that wt-p53 re-expression is able to suppress the in vitro tumorigenic potential of ARO cells.
Wt-p53 restores thyroid-speci®c dierentiation in ARO cells
Among the dierent thyroid tumor histotypes, anaplastic carcinoma shows the unique association between loss of thyroid dierentiation properties and alteration of p53 function. Recent reports have suggested that p53, other than acting as an inhibitor of cell proliferation, could also play a role in the process of cell dierentiation (Shaulsky et al., 1991b;  Figure 5 Expression and TSH responsiveness of p21/WAF1 gene in ARO cell clones. Northern blot analysis was performed on total RNA extracted from control ARO-Neo and the indicated ARO-tsp53 transfected clones, cultured at 378C (37) or at 328C (32) for 4 days and maintained, for further 3 days, in the presence (+) or absence (7) of 10 mU/ml TSH. RNA was size-fractionated on a 1.2% agarose gel, vacuum-blotted on a Duralose membrane, hybridized with 32 P-labeled p21/WAF1 cDNA and assessed by autoradiography (upper panel). Membranes were rehybridized with the house-keeping 32 P-labeled GAPDH cDNA (lower panel) to determine RNA loading -Grinstein et al., 1993; Battista et al., 1995; Fagin et al., 1996; Soddu et al., 1996) . For these reasons we investigated whether wt-p53 re-expression could also modulate the impaired thyroid dierentiation pathway of ARO cells. Expression of the thyroid-speci®c genes Tg, TPO and TSH-R, was evaluated by measuring cytoplasm mRNA levels in the various ARO clones. In agreement with Namba et al. (1992) , who reported that ARO cells express very low levels of TSH-R mRNA, detectable only by RT ± PCR analysis, we were not able to detect Tg, TPO and TSH-R mRNA signals by Northern analysis. The three thyroid-speci®c mRNAs and the house-keeping aldolase mRNA, co-ampli®ed as an external standard, were therefore analysed by semiquantitative RT ± PCR, performed at least 9 times starting from three dierent RNA preparations.
Negative (no template) and positive (human thyroid RNA) controls were run to check for DNA and PCR product contaminations as well as to properly set up semi-quantitative RT ± PCR conditions (see Materials and methods) (Figure 7a ). mRNAs for TSH-R, Tg and TPO were all present, although at very low levels, in all ARO clones (Figure 7b ). In particular, in unstimulated conditions, expression of these genes in ARO-tsp53 clones was not moditifed after incubation either at 378C or 328C, as indicated by the ratios between mRNA levels at the two temperatures (Figure 7b , subscribed numbers). Hence, we can conclude that wtp53 re-expression per se does not appear to aect ARO cell dierentiation. Thyrocytes exhibit specialized functions and express thyroid-speci®c biochemical markers, such as Tg, TPO a p53 re-expression in thyroid carcinoma cells F Moretti et al and TSH-R, which are modulated by TSH. ARO cells, however, are TSH-independent, both in terms of proliferation and expression of thyroid-speci®c genes . Since it has been reported that wt-p53 is able to restore responsiveness to cytokine signals in leukemic cells (Yonish-Rouach et al., 1991; Johnson et al., 1993) , we investigated whether AROtsp53 clones re-acquired responsiveness to the thyrocyte physiological stimulus, TSH. To this purpose, expression of thyroid-speci®c genes was investigated in ARO-tsp53 clones, cultured at 328C for 4 days and then for further 3 days in the presence or absence of a standard TSH concentration (10 mU/ml). TSH-R, Tg and TPO mRNA levels were all markedly increased following TSH stimulation (Figure 8 ). On the contrary, ARO-Neo and ARO parental cells did not show any variation in the expression of thyroid-speci®c genes, regardless of TSH presence. The possibility that the increased expression of thyroid-speci®c mRNAs could be due to a generalized increase of transcription induced by TSH was ruled out by the observation that mRNA levels for the house-keeping aldolase gene were constant in all culture conditions tested (Figure 8 , Aldo). These data suggest that wt-p53 re-expression is able to restore ARO cell responsiveness to TSH stimulation. It has been recently reported that induction of dierentiation is accompanied by an increased expression of p21/Waf1 gene (Steinman et al., 1994; Jiang et al., 1994; Parker et al., 1995; Macleod et al., 1995) . Expression of p21/Waf1 was therefore investigated in ARO-tsp53 clones, cultured at 328C in the presence or absence of TSH. The results showed that, in three ARO-tsp53 clones (ARO-1F, ARO-4F and ARO-5), p21/Waf1 mRNA levels, already increased following wt-p53 re-expression, raised after TSH addition to culture medium ( Figure 5 and Table 2 , with TSH). It is therefore possible to speculate that TSH stimulation, while inducing thyroid-speci®c gene expression, is also able to modulate p21/Waf1, in agreement with the hypothesis underlying a role for this gene in the process of cell dierentiation.
Discussion
Functional alterations of the tumor suppressor p53 gene in thyroid neoplasia, have been found almost exclusively in poorly dierentiated and anaplastic thyroid carcinomas (Wright et al., 1991; Ito et al., 1992; Fagin et al., 1993; Donghi et al., 1993) . In this regard it is noteworthy the observations by Donghi et al. (1993) who found that, inside a thyroid tumor composed by two areas with varying degrees of dierentiation, p53 gene mutation was restricted to the less dierentiated area of the neoplasia. These observations have raised the hypothesis that derangement of p53 function could be correlated to the loss of the dierentiated properties of the thyrocyte and to the acquisition of the highly invasive and aggressive behaviour of undierentiated thyroid carcinomas.
In this study we have investigated the possibility that re-expression of wild type-p53 in human thyroid anaplastic carcinoma cells may interfere with their neoplastic behaviour and/or modulate the re-acquisition of thyrocyte dierentiation properties. For this purpose, we have stably transfected a temperaturesensitive mutant p53 into the human thyroid anaplastic carcinoma cell line ARO, which expresses a mutant (His 273 ) p53 allele while lacking the other allele. The results demonstrate that recovery of wt-p53 activity in ARO cells, provides for (1) a strong reduction in the proliferation rate which coincides with an accumulation in the G 1 phase of the cell cycle, (2) a complete loss of the in vitro tumorigenic potential, (3) the reappearance of typical thyrocyte dierentiated properties, such as the induction of the thyroid speci®c genes Tg, TPO and TSH-R upon TSH stimulation.
The present ®ndings, demonstrating the ability of wt-p53 in reducing ARO cell proliferation rate, are in keeping with those reported in the literature concerning the growth inhibitory activity of p53 in transformed cell lines (Michalovitz et al., 1990 ; Expression of thyroid speci®c genes in ARO cell clones. Total RNA was extracted from ARO cell clones grown at 378C or at 328C and RT ± PCR analysis performed by using intron-spanning primers speci®c for the thyroid-speci®c genes: TSH receptor (TSH-R; row A), thyroglobulin (Tg; row B) and thyroperoxidase (TPO; row C). The relative intensity of the bands was quantitated by densitometry and normalized to the co-ampli®ed aldolase signal (Aldo Mercer et al., 1990; Baker et al., 1990; Shaulsky et al., 1991b; Feinstein et al., 1992; Johnson et al., 1993; Fagin et al., 1996) . The coupling of wild type p53 function with inhibition of the progression from G 0 /G 1 to the S phase of the cell cycle, is a well characterized ®nding and appears to be mediated by increased p21/ Waf1 expression. In agreement with these observations, our results show that inhibition of cell proliferation in ARO-tsp53 clones is accompanied by a delay of the G 1 /S transition and by induction of p21/Waf1 gene expression. The inhibition of AROtsp53 cell proliferation did not appear to be caused by increased cell death, as judged by estimation of cell viability curves and cell cycle analysis. However, it cannot be excluded that attainment of higher expression levels of exogenous p53 might modulate a ®nal outcome generating cell death instead of growth inhibition. Indeed, in HL60 cells, dierentiation and apoptosis depend upon the levels of wt-p53 expression reached after vaccinia virus infection (Ronen et al., 1996) . It has been reported that induction of dierentiation in human hematopoietic cells and in pre-B and B cells is accompanied by p53 upregulation (Kastan et al., 1991; Aloni-Grinstein et al., 1993) and that overexpression of wt-p53 in transformed cell lines induces the expression of speci®c dierentiation markers (Shaulsky et al., 1991b; Feinstein et al., 1992; Johnson et al., 1993; Brenner et al., 1993; Soddu et al., 1994; Fagin et al., 1996) . In this regard, we analysed whether re-expression of wt-p53 in ARO cells was able to induce the expression of thyroid dierentiation markers (Tg, TPO and TSH-R). The results showed that wt-p53 re-expression is not able per se to modulate the expression of these markers. However, following TSH treatment, ARO-tsp53 clones exhibited a dierentiated phenotype with increased expression of Tg, TPO, and TSH-R mRNAs. In keeping with these results are recent observations showing that wt-p53 overexpression in transformed cell lines is able to modulate their responsiveness to appropriate stimuli (Yonish-Rouach et al., 1991; Brenner et al., 1993; Johnson et al., 1993) . Therefore, re-expression of wt-p53 in ARO cells leads to restoration of responsiveness to their physiological stimulus. This eect might be due to a recovery of the TSH receptor transduction pathway, since it has been shown that, in ARO cells, TSH receptor is able to bind its ligand with unaltered anity but shows an impaired function, probably due to a defect in the receptorcoupling system (Pang et al., 1989; Namba et al., 1992; Kimura et al., 1992) . Another explanation relies on the hypothesis that re-expression of wt-p53 could act bỳ normalizing' the transformed phenotype of ARO cells, thus rendering them again responsive to exogenous and/or endogenous stimuli. The latter hypothesis is also supported by the ®nding that ARO-tsp53 cells completely loose their in vitro tumorigenic potential.
Interestingly, TSH-R mRNA was positively regulated following TSH treatment, a ®nding which may contrast with the`down-regulation' usually elicited by hormones toward their speci®c receptors. Our observations, however, are in good agreement with the results TSH responsiveness of ARO cell clones. Total RNA was extracted from ARO cell clones grown for 4 days at 328C and for a further 3 days in the presence (+) or absence (7) of 10 mU/ml TSH. RT ± PCR analysis was performed by using intronspanning primers speci®c for the thyroid-speci®c genes: TSH receptor (TSH-R; row A), thyroglobulin (Tg; row B) and thyroperoxidase (TPO; row C). The relative intensity of the bands was quantitated by densitometric analysis and normalized to the co-ampli®ed aldolase mRNA signal (Aldo). Normalized values were used to calculate ratios (subscribed numbers), in TSH stimulated (+TSH) vs unstimulated (7TSH) conditions, for each thyroid-speci®c marker. M, molecular size marker (Marker VI, Boehringer Mannheim)
p53 re-expression in thyroid carcinoma cells F Moretti et al obtained by Huber et al. (1992) and Maaenhaut et al. (1992) in human thyroid monolayer cells, which also demonstrated upregulation of TSH-R expression following TSH stimulation. Receptor recruitment is also a characteristic of other pituitary glycoproteic hormones such as FSH, a phenomenon which is used in current therapeutic protocols for the induction of ovulation in the infertile women. Attempts to demonstrate the re-acquistion of more complex, thyrocyte function, such as iodine uptake or cAMP stimulation, were also performed in ARO-tsp53 clones but the results were negative. We do not know whether this lack of eect is due to an incomplete recovery of thyroid-speci®c dierentiation or it is the consequence of the low cell incubation temperature (328C) which is necessary to elicit wt-p53 activity. The latter hypothesis is supported by the marked decrease of iodine uptake showed at 328C also by control rat FRTL-5 cells, a cell line which possess a fair ability to trap iodine.
In agreement with the hypothesis that p53 plays a role in thyrocyte dierentiation, two recent reports substantiate a direct involvement of p53 in the thyroid dierentiation process. Battista et al. (1995) showed that transfection of a mutated p53 in a nontransformed rat thyroid cell line interfered with thyroid-speci®c functions, particularly by inhibiting the expression of Pax-8, a transcription factor involved in thyroid-speci®c gene expression. A mirror image of these results was obtained by Fagin et al. (1996) who showed a positive eect on the thyroidspeci®c enzyme TPO and on Pax-8 expression, following transfection of a wt-p53 in a human thyroid papillary carcinoma cell line characterized by the presence of a heterozygous p53 mutation. Although both studies con®rm a possible role of p53 along the thryoid dierentiation pathway, the latter is not entirely comparable to ours, mainly because of dierences in the cellular and genetic context and because the eect of TSH stimulation was not investigated.
In our model, the partial re-acquisition of a thyroid dierentiation phenotype is also accompanied by increase of p21Waf1/mRNA levels in the presence of TSH. This result is in agreement with recent reports suggesting that p21/Waf1 is an early marker of dierentiation, which contributes to cell cycle arrest and cell dierentiation by distinctive pathways (Steinman et al., 1994; Parker et al., 1995) .
In conclusion, our results indicate that wt-p53 reexpression in human thyroid anaplastic carcinoma cells can interfere and partially revert their malignant and undierentiated phenotype. In this respect, attempts at exploring the possibility of`normalizing' neoplastic thyroid cell behaviour may be of interest in view of future applications in the clinical practice.
Materials and methods
Cell cultures, plasmids and transfections
The human thyroid anaplastic carcinoma cell line, ARO, was cultured in RPMI 1640 medium supplemented with 10% heat-inactivated fetal bovine serum (Gibco-BRL, Life Technologies). ARO cells are characterized by the deletion of one p53 allele and by the presence, on the other allele, of a G : C to A : T transition at codon 273, resulting in the substitution of an arginine with a histidine residue (Fagin et al., 1993) . This mutation is responsible for the alteration of p53 transcriptional activity, due to impairment of p53 binding to the speci®c DNA recognition sites on target genes .
Plasmid pN53cG (Val 135 ), coding for the temperature sensitive murine p53 Val 135 mutant gene, and the selectable marker neo, under the control of the RSV-LTR promoter (tsp53), was used to stably transfect ARO cells. The p53 Val 135 protein has a mutant conformation at 378C while displays a wild type-like activity at 328C (Gisberg et al., 1991) . The plasmid pRSVneo (Neo), carrying only the selectable marker neo under the control of the RSV-LTR promoter, was used as control. Approximately, 2610 6 exponentially growing ARO cells were stably transfected by electroporation (0.25 V, 960 mF) with a Gene Pulser (Bio-Rad Laboratories Inc., Hercules, CA). Single cell clones were selected in medium containing 1 mg/ml G418 (Gibco-BRL).
Plasmid PG 13 CAT, carrying the CAT reporter gene driven by the polyoma virus early promoter and 13 repeats of a p53-binding sequence, or plasmid MG 15 CAT, containing 15 repeats of a mutated p53-binding site (Kern et al., 1992) , were transiently transfected in ARO cells clones by calcium phosphate precipitation technique. In 60 mm plates, 4610 5 cells were transfected with aliquots of precipitates containing: (1) 10 mg of PG 13 CAT or MG 15 CAT or SV40CAT; (2) 1 mg of CMVb-gal plasmid, an internal control of transfection eciency. Cells were harvested 72 h after transfection and CAT activity was assayed on whole cell extracts as described (Desvergne et al., 1991) .
Proliferation rate and cell cycle analysis
Cell proliferation rate was assessed by determining cell number in a Thomas's hemocytometer, using Trypan blue exclusion as cell viability test. Cell cycle pro®le was evaluated by ®xing 2610 5 cells in cold acetone : methanol (1 : 4) for 30 min at 48C and staining DNA for 30 min at room temperature with 50 mg/ml propidium iodide in PBS containing 1 mg/ml RNAse A. Cellular DNA content was measured by an Epics XL analyser (Coulter Corp, Miami, FL) by acquiring at least 10 4 events/sample. The percentage of cells in the dierent cell cycle compartments was estimated by applying a mathematical model to each histogram, based on the maximum likelihood approach (Lampariello et al., 1991) .
Anchorage-independent growth
To determine the ability of the various ARO clones to form colonies in soft agar, 1610 4 cells were seeded in 60 mm dishes onto 0.3% Noble Agar on top of a 0.6% bottom layer. Colonies larger than 50 cells were scored after 2 weeks incubation either at 328C or 378C.
Northern blot analysis
Total RNA was extracted by the guanidinium isothiocyanate acidic phenol method (Chomczynski and Sacchi, 1987) from ARO clones, incubated, either at 328C or 378C for 4 days, and then, for additional 3 days, in the presence or absence of TSH (10 mU/ml). 25 mg of total RNA/lane were separated on a 1.2% agarose-formaldehyde gel, vacuumblotted on a Duralose membrane (Stratagene), covalently bound by brief u.v. exposure, hybridized to radiolabeled probes for 12 h and autoradiographed. Densitometric analysis of autoradiograms was performed on a GS-700 Imaging Densitometer (Bio Rad, CA, USA) and results expressed as relative fold of induction, at 328C vs 378C, after normalization for control GADPH mRNA levels. RT ± PCR analysis of thyroid-speci®c mRNAs RT ± PCR was performed as described (Kawasaki, 1990) with minor modi®cations: 5 mg of total RNA were reverse transcribed at 428C for 45 min in the presence of random examers and Moloney murine leukemia virus reverse transcriptase (Gibco-BRL). 5 ml of the cDNA reaction were then subjected to PCR in a ®nal volume of 50 ml PCR buer (50 mmol/l KCl, 10 mmol/l Tris-HCl, pH 8.3, 1.5 mmol/l MgCl 2 , 0.01% gelatin) containing 200 mmol/l each dNTP, 0.5 units Taq polymerase (Perkin Elmer, Norfolk, CT, USA) and 0.4 mmol/l of speci®c intronspanning primers. Tg mRNA analysis was carried out by PCR ampli®cation of a fragment of 544 bp using the following primers: forward primer (exon 1: 6 ± 27), 5'-CCTGGTCCTGGAGATCTT-CACC-3', reverse primer (exon 5: 550 ± 529) 5'-AA-CACTGGGGTGGTGACTTATC-3'. PCR was performed for a total of 35 cycles, each consisting of 1 min at 948C, 1 min at 588C, and 1 min at 728C. For TSH-R mRNA analysis, a fragment of 410 bp was obtained, using the following primers: forward primer (exon 7: 690 ± 710) 5'-TCAATGGGACAAAGCTGGAT-3', reverse primer (exon 10: 1100 ± 1080) 5'-TGCTGTCACCCAGATTCTCT-3' . PCR was performed for a total of 40 cycles, with a pro®le similar to that used for Tg, except for the annealing temperature of 658C. For TPO mRNA analysis, a fragment of 386 bp was obtained, using the following primers: forward primer (exon 12: 2185 ± 2205) 5'-AACACTGGCCTCACCAGGGT-3', reverse primer (exon 14: 2571 ± 2551) 5'-TCCGCGCAGAGACACTGGAA-3'. PCR was performed for a total of 40 cycles with the same pro®le used for Tg analysis, except for the annealing temperature of 588C. The house-keeping aldolase mRNA was used as external standard and co-ampli®ed, in the same reaction tube, with the other thyroid-speci®c markers, using the following primers: forward primer 5'-CAGCTCCTT-CTTCTGCTGCGGGGTC-3', reverse primer 5'-CGCAGA-AGGGGTCCTGGTGA-3' (Chelly et al., 1988) . PCR conditions were the same as those used for the amplification of each single thyroid-speci®c cDNA fragment.
PCR products were electrophoresed onto a 2% agarose gel containing ethidium bromide (0.5 mg/ml) and visualized under u.v. light. The relative intensity of the bands was quantitated by densitometric analysis and normalized to the co-ampli®ed aldolase cDNA fragment. Preliminary experiments were performed to determine the exponential phase of ampli®cation for each marker using RNA extracted from human normal thyroid tissue as positive control. The optimal ratio between the dierent primer couples, used in amplifying aldolase and the various thyroid-speci®c markers, was: 1 : 1 for Tg, 1 : 4 for TSH-R, and 1 : 2 for TPO. Densitometric values were used to calculate ratios for each thyroid-speci®c marker under the dierent incubation conditions. At least 9 RT ± PCR experiments were performed starting from three dierent RNA preparations, obtained after incubation of ARO cell clones, either at 378C or 328C, in the presence or absence of TSH, as described above. No ampli®cation of fragments longer than the expected bands was ever observed in the RT ± PCR experiments, indicating lack of interference from potential DNA contaminants. Negative controls without cDNA were also run at the beginning and at the end of each single PCR experiment to check for contamination by products from previous PCR.
Indirect immuno¯uorescence
Approximately 4610
4 ARO cells were plated on a 35 mm Petri dish and grown at 328C for 3 days. Cells were ®xed in acethone : methanol (1 : 1) for 5 min at room temperature, rehydrated and incubated for 1 h at 378C with monoclonal antibody PAb421 (Oncogene Science, Uniondale, NY) which recognizes p53 protein of a broad range of mammalian species. After washing, cells were incubated for 1 h with FITC-conjugated goat anti-mouse IgG. Localization and intensity of¯uorescence were observed with¯uorescence microscopy.
Western blot analysis
Approximately 5610 6 cells, cultured at 378C, were incubated for 30 min at 48C in lysis buer (20 mM Tris, pH 7.8; 50 mM NaCl; 5 mM EDTA; 1% Triton X-100; 0.2% SDS; 0.5% Sodium deoxycholate; 1 mM PMSF). The lysate was centrifuged at 10 000 g for 30 min and the protein content in the supernatant measured (Bio-Rad). Fifty mg of proteins per sample were loaded onto a 10% SDS-polyacrylamide gel, electrophoresed, and then electroblotted onto nitrocellulose membranes (Bio-Rad). Filters were blocked for non-speci®c reactivity by incubation for 1 h at room temperature in 2% non-fat dry milk dissolved in TBST (20 mM Tris-HCl pH 7.8; 150 mM NaCl; 0.02% Tween 20), and then probed with anti-p53 PAb240 antibody (Oncogene Science), diluted in TBST at a concentration of 0.5 mg/ml for 2 h at room temperature under gentle rocking. PAb240 antibody recognizes mutant p53 protein on a broad mammalian spectrum. P53 immunoreactivity was determined using ECL-chemiluminescence reaction (Amersham Corp, Arlington Heights, IL) following manufacturer's instructions.
